3 Reasons Pfizer Stock Could Be a Steal of a Deal in 2025
If you're looking for reasonably priced stocks to pick up right now, you shouldn't overlook Pfizer (NYSE: PFE). The pharmaceutical giant isn't as risky an investment as it may appear to be. Its financials aren't in bad shape, and while the stock has been struggling, now could make a great time to load up on it.Here are three reasons why Pfizer could prove to be a steal of a deal this year.Buying quality stocks at decent valuations can give you a good margin of safety and minimize your investment risk. And while many stocks trade at cheap valuations because they are highly risky, that isn't the case with Pfizer. Continue reading
If you're looking for reasonably priced stocks to pick up right now, you shouldn't overlook Pfizer (NYSE: PFE). The pharmaceutical giant isn't as risky an investment as it may appear to be. Its financials aren't in bad shape, and while the stock has been struggling, now could make a great time to load up on it.
Here are three reasons why Pfizer could prove to be a steal of a deal this year.
Buying quality stocks at decent valuations can give you a good margin of safety and minimize your investment risk. And while many stocks trade at cheap valuations because they are highly risky, that isn't the case with Pfizer.
